Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

Q: What does CUSIP 877619106 represent in this 13F holders report?

CUSIP 877619106 is the security identifier for TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in Q2 2022?

55 institutional investors reported TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 877619106

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.00001 per share
Shares outstanding: 275,000,000
Total 13F shares: 14,700,530
Share change: -2,290,617
Total reported value: $54,695,000
Put/Call ratio: 0%
Price per share: $3.72
Number of holders: 55
Value change: -$11,594,670
Number of buys: 28
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 877619106?
CUSIP 877619106 identifies TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 877619106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	1.2%	3,294,821	$21,483,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	0.8%	2,193,703	$14,300,000	—	31 Mar 2022	13F
Nantahala Capital Management, LLC	13F	Company	0.49%	1,333,947	$8,697,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.47%	1,300,668	$8,480,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	0.38%	1,040,882	$6,787,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	0.37%	1,012,164	$6,599,000	—	31 Mar 2022	13F
Sands Capital Alternatives, LLC	13F	Company	0.26%	724,873	$4,726,000	—	31 Mar 2022	13F
TimesSquare Capital Management, LLC	13F	Company	0.24%	665,900	$4,342,000	—	31 Mar 2022	13F
Alphabet Inc.	13F	Company	0.23%	640,882	$4,179,000	—	31 Mar 2022	13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	13F	Company	0.18%	500,000	$3,260,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.18%	499,214	$3,255,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.16%	439,804	$2,868,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	409,570	$2,670,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.09%	250,500	$1,633,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	208,749	$1,361,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.07%	205,625	$1,340,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.07%	181,908	$1,186,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.06%	175,755	$1,148,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	165,345	$1,079,000	—	31 Mar 2022	13F
Quantum Private Wealth, LLC	13F	Company	0.06%	151,974	$990,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.05%	139,386	$909,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.05%	136,300	$889,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.04%	117,109	$764,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.04%	103,100	$672,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.04%	105,426	$665,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	89,039	$580,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.03%	78,237	$510,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.03%	74,734	$487,000	—	31 Mar 2022	13F
Trexquant Investment LP	13F	Company	0.03%	71,483	$466,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	71,357	$465,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.02%	67,980	$443,000	—	31 Mar 2022	13F
1623 Capital LLC	13F	Company	0.02%	46,763	$305,000	—	31 Mar 2022	13F
THOMPSON SIEGEL & WALMSLEY LLC	13F	Company	0.02%	42,100	$274,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.02%	44,387	$273,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.01%	41,000	$267,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	33,694	$220,000	—	31 Mar 2022	13F
DAVENPORT & Co LLC	13F	Company	0.01%	27,670	$180,000	—	31 Mar 2022	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.01%	26,328	$172,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	24,435	$159,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	22,389	$146,000	—	31 Mar 2022	13F
Mitsubishi UFJ Asset Management Co., Ltd.	13F	Company	0.01%	21,834	$142,000	—	31 Mar 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.01%	20,000	$131,000	—	31 Mar 2022	13F
NISA INVESTMENT ADVISORS, LLC	13F	Company	0.01%	19,800	$129,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.01%	18,928	$123,000	—	31 Mar 2022	13F
Caption Management, LLC	13F	Company	0.01%	18,191	$119,000	—	31 Mar 2022	13F
Legal & General Group Plc	13F	Company	0.01%	16,100	$104,000	—	31 Mar 2022	13F
CREDIT SUISSE AG/	13F	Company	0.01%	15,144	$99,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	14,291	$93,000	—	31 Mar 2022	13F
Jump Financial, LLC	13F	Company	0%	13,700	$89,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0%	12,366	$81,000	—	31 Mar 2022	13F

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q2 2022

As of 30 Jun 2022, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,700,530 shares. The largest 10 holders included FMR LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Artal Group S.A., FRANKLIN RESOURCES INC, Sands Capital Ventures, LLC, Alphabet Inc., RENAISSANCE TECHNOLOGIES LLC, and TYBOURNE CAPITAL MANAGEMENT (HK) LTD. This page lists 55 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-15

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.